Good pharmacovigilance practice

Impact of the amended CIR 520/2012 to UK authorised products

Posted by: , Posted on: - Categories: Good pharmacovigilance practice, GPvP, Pharmacovigilance

From 12 February 2026, amendments to the EU Commission Implementing Regulation (CIR) 520/2012 come into effect. While the UK operates an independent regulatory system, these changes have practical implications for some UK-authorised products, particularly in relation to pharmacovigilance (PV) requirements. …

Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium

Posted by: , Posted on: - Categories: Good pharmacovigilance practice, Inside the Inspectorate

The world of GPvP is highly regulated, but the 2024 GPvP symposium showcased how regulation, collaboration and innovation can work together to enhance compliance, provide opportunities for better ways of working, and improve patient lives. The Symposium welcomed over five …

Pharmacovigilance Inspection Metrics April 2020 to March 2021

Posted by: , Posted on: - Categories: Compliance matters, Good pharmacovigilance practice
analysing data with a magnifying glass

The MHRA GPvP Inspection Metrics report for the period April 2020 to March 2021 is now available. Read the full metrics report published on GOV.UK. We hope that the report is informative and useful for considering compliance and improvements within …

Inspectors grounded - a year of innovation

The start of lockdown this time last year meant a complete change to the way of working for the inspectorate, with the potential to impact dramatically on our ability to maintain regulatory oversight of public health

Pharmacovigilance requirements for UK authorised products - 13 January 2021

Posted by: , Posted on: - Categories: Compliance matters, Events and symposia, Good pharmacovigilance practice, Wider MHRA

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020. This webinar was part of a series of Brexit and post-transition guidance webinars.